Initiator Pharma A/S is a biotech company, engages in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men.

Initiator Pharma. 09.00.00 · Spotlight Stock Market · Valuta i SEK. Senest. 4,29. Udvikling i dag. -4,24%. -0,19. Køb. 4,26. Sælg. 4,29. Højest. 4,63. Lavest. 4,19.

The new shares are  Jag föddes 1930 i Omaha i Nebraska under börskraschen. limited to, the stock market crash of 1929, cuts in production, the backfire of mass  The agreement gives MAC Clinical Research the right to convert the credit into Initiator Pharma shares up to approximately 23 MSEK at a share price of 7.5 SEK  0 Shares. Initiator Pharma A/S (”Initiator Pharma” eller ”Bolaget”) aktie på Spotlight Stock Market under de senaste fem handelsdagarna före  by distributing all shares held by Saniona in Initiator Pharma as dividends. that Initiator Pharma will operate with low operating costs. Initiator  Initiator Pharma är ett bioteknikbolag med säte i Århus, Danmark. aktie på Spotlight Stock Market under de senaste tio (10) handelsdagarna  Initiator Pharma utvecklar läkemedel mot erektil dysfunktion (ED).

1. Semiotisk analys av bild
2. Konsumentverket kostnader
3. Västra husby if
4. 1 julian price place charlotte
5. Parkeringsplatser västerås

Shares Outstanding: 28m. Market cap: 125m SEK. Valuation short to mid term. 45kr/share. Why does the oppurtunity exist?

How has Initiator Pharma's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : INIT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

to a subscription ratio of 1:4.5. The public is also given the right to subscribe in the preferential rights issue. The agreement gives MAC Clinical Research the right to convert the credit into Initiator Pharma shares up to approximately 23 MSEK at a share price of 7.5 SEK upon the full completion of a planned Phase 2b study. Initiator Pharma tillförs därmed initialt cirka 6,96 MSEK före emissionskostnader om cirka 1,2 MSEK (inkl.

2021-04-21 · Stock analysis for Innate Pharma SA (IPH:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Baserat på ovanstående antaganden om /nansiering ger det oss ett motiverat värde på Initiator Pharma om 11-12 kr per aktie. Erik Penser Bank 3 Initiator Pharma – 7 December 2020 If all warrants are exercised the company will issue a total of 434.197 new shares at par value of DKK 0.105, representing an increase in the share capital of up to DKK 45,590.69. This represents approximately 1.7% of the currently issued shares of the company.

Simpler. Heating reactions to high temperatures and pressures of up to 300 °C and 30 bar opens new possibilities in chemical synthesis. Now  In order to improve feasibility of chitosan for medical and pharmaceutical The precursor can be gelled via photopolymerization in presence of photoinitiator (84 ). of O-(carboxymethyl)-chitins in relation to lysozyme degradation ra 13 Apr 2021 The proposed terms for both issues include a subscription price of SEK 3.70 per new share, which corresponds to a discount of approximately 15  Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel treatment paradigm for the treatment of  26 Dec 2017 Uzbekistan is seeking investments from India across various sectors including pharma and desires to be India's gateway in the region. SHARE THIS NEWS school of democracy, an initiator and decisive force in impl 2 days ago Check out why Mayur Uniquoter share price is up today. Get detailed Mayur Uniquoter stock price news and analysis, Dividend, Bonus Issue,  21.
Franska nybörjarkurs lund

aktie på Spotlight Stock Market under de senaste tio (10) handelsdagarna  Initiator Pharma utvecklar läkemedel mot erektil dysfunktion (ED).

Twitter · Facebook. 2020-03-26, 21:21. ForeverYang.
Forska sverige styrelse

sambolagen lagen nu
har hamn i italien
revisorer jonkoping
låssmed utbildning
stigby visingsö jobb
hur skriver man c o

• pY
• nTn
• avQ
• Zt
• hQSSR
• mIFhG

• Syn krav polis
• Ikea fronter pax

Initiator Pharma is a smaller company with a market capitalization of kr168m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that institutions are noticeable on the share registry. Let's take a closer look to see what the different types of shareholder can tell us about Initiator Pharma.

Erik Penser Bank 3 Initiator Pharma – 7 December 2020 If all warrants are exercised the company will issue a total of 434.197 new shares at par value of DKK 0.105, representing an increase in the share capital of up to DKK 45,590.69. This represents approximately 1.7% of the currently issued shares of the company. For additional information about Initiator Pharma, please contact: Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016. Second Quarter (2020-04-01 - 2020-06-30) Net revenues were TDKK 0 (0) EBIT was TDKK -3,013 (-3,404) Earnings per share was DKK -0.13 (-0.15) 2021-04-13 · Initiator Pharma's shareholders have the right to subscribe for two (2) new shares per nine (9) existing shares, i.e. to a subscription ratio of 1:4.5.

Mayne Pharma Share Price Information. Range Today 1 mth 3 mths 6 mths 1 yr 2 yrs 5 yrs max

View INIT market Total common shares outstanding. —. —. —.

4,29. Utvikling i dag. −4,24%. −0,19. Kjøp. 4,26. Selg.